Strengthening HIV-prevention trials: a dose of implementation science?

Lancet Infect Dis. 2018 Nov;18(11):1166-1168. doi: 10.1016/S1473-3099(18)30567-X. Epub 2018 Oct 24.

Authors

Elvin H Geng¹, David V Glidden², Nancy Padian³

Affiliations

¹ University of California, San Francisco, CA 94117, USA. Electronic address: elvin.geng@ucsf.edu.
² University of California, San Francisco, CA 94117, USA.
³ University of California, Berkeley, CA, USA.

PMID: 30507394
DOI: 10.1016/S1473-3099(18)30567-X

No abstract available

Publication types

Comment

MeSH terms

Double-Blind Method
Female
HIV Infections*
HIV-1*
Humans
Implementation Science
South Africa
Tenofovir
Vaginal Creams, Foams, and Jellies

Substances

Vaginal Creams, Foams, and Jellies
Tenofovir